Monoclonal Antibody Targets, Kills Leukemia Cells
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.
Health & Behavior
The Latest
UC San Diego Pharmacy School Benefactor “Sam” Skaggs Dies at 89
L.S. “Sam” Skaggs, whose enduring support of pharmacy education and research helped fuel the growth and development of the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego, died Thursday at the age of 89 of causes related to age.
Kidney Sparing Surgery Underutilized for Patients Who Need It Most
Researchers at the University of California, San Diego School of Medicine have released study results that show national treatment trends in the surgical management of patients with kidney disease. The study found that partial and complete kidney removal (total nephrectomy) and energy-based techniques to destroy tumors are all on the rise. Surprisingly, the patients most in need of kidney-sparing surgery are still more likely to undergo total nephrectomy.
Beyond the Campaign Poster: UC San Diego’s United Way/CHAD Campaign
Every February, posters for UC San Diego’s United Way/CHAD Campaign begin to appear in campus elevators, break-rooms, hallways and offices. Invitations to fundraising events and requests to make a pledge to the campaign follow. For some, that’s where their involvement with the campaign ends.
New Imaging Agent Enables Better Cancer Detection, More Accurate Staging
Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye, designed and developed at UC San Diego Moores Cancer Center, is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the current standard dye.
UC San Diego Moores Cancer Center New Member of National Comprehensive Cancer Network
On March 19, the National Comprehensive Cancer Network® announced the election of University of California, San Diego Moores Cancer Center as the first and only San Diego-based NCCN Member Institution dedicated to improving the quality, effectiveness, and efficiency of care provided to patients with cancer.
Stay in the Know
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
